Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03142737 · ClinicalTrials.gov registry record · NA
Are the "ounce-equivalents" in the Protein Foods Groups Really Equivalent?
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03142737: Completed NA study, sponsored by University of Arkansas.
NCT03142737 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03142737, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The investigators will determine effects of different sources of protein on whole-body net protein synthesis and muscle protein synthesis in young healthy participants.
Primary Outcome
Net protein synthesis rate is determined in the 4.5-hour basal fasted period and 4-hous post-meal period over the 8.5-hour experimental period
Interventions
- OTHER Red kidney bean intake
- OTHER Eggs intake
- OTHER Peanut butter intake
- OTHER Ground beef intake
- OTHER Intact beef intake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2019-05-15 |
| Phase | NA |
What the finished NCT03142737 record still lists
NCT03142737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Red kidney bean intake is the first listed.
NCT03142737 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03142737 about?
NCT03142737 is a clinical study titled "Are the "ounce-equivalents" in the Protein Foods Groups Really Equivalent?". The investigators will determine effects of different sources of protein on whole-body net protein synthesis and muscle protein synthesis in young healthy participants.
What is the current status of trial NCT03142737?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2017-05-08. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT03142737?
The interventions under investigation include: Red kidney bean intake (OTHER), Eggs intake (OTHER), Peanut butter intake (OTHER), Ground beef intake (OTHER), Intact beef intake (OTHER).
Who is sponsoring clinical trial NCT03142737?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03142737's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI